Molbio Diagnostics IPO GMP, Open Date, Price Band, Issue Size

Molbio Diagnostics IPO open date is August 10, 2026, and the closing date is August 12, 2026. This new IPO is a book-built issue of 1,16,46,246 equity shares aggregating up to Rs 940 crore. This upcoming IPO consists of a fresh issue of 24,80,246 equity shares aggregating up to Rs 200 crore and an offer for sale of 91,66,000 equity shares aggregating up to Rs 740 crore.

Molbio Diagnostics IPO price band is Rs 768 to Rs 807 per share. As of August 5, 2026, the Molbio Diagnostics IPO GMP Live quotation is at Rs 0 per share. Live IPO Grey Market Premium details will be available online.

Molbio Diagnostics IPO allotment status will be available on August 13, 2026. Molbio Diagnostics IPO lot size is 18 shares. The minimum investment for retail investors for 1 lot is Rs 14,526. The registrar for the Molbio Diagnostics IPO is Kfin Technologies Limited. Molbio Diagnostics IPO listing date is August 17, 2026.

Molbio Diagnostics IPO GMP

Molbio Diagnostics IPO GMP is Rs 0 per share as on August 5, 2026. You can check the latest IPO Grey Market Premium online from the first day of subscription. If the subscription is oversubscribed, then Molbio Diagnostics IPO GMP might rise.

Molbio Diagnostics IPO Open Date, Close Date

Molbio Diagnostics IPO open date is August 10, 2026, and the IPO close date is August 12, 2026. The initiation of the refund date is August 14, 2026, and the credit of shares will be on August 14, 2026.

Molbio Diagnostics IPO Price Band

Molbio Diagnostics IPO price band is Rs 768 to Rs 807 per share. The minimum amount of investment for the retail category is Rs 14,526, and for small HNI, the minimum investment is Rs 2,03,364. The minimum investment for the Big HNI is Rs 10,02,294.

Molbio Diagnostics IPO Issue Size

Molbio Diagnostics IPO is a book-built issue of 1,16,46,246 equity shares aggregating up to Rs 940 crore. The issue comprises a fresh issue of 24,80,246 equity shares aggregating up to Rs 200 crore and an offer for sale of 91,66,000 equity shares aggregating up to Rs 740 crore.

Molbio Diagnostics IPO Allotment Status

Molbio Diagnostics IPO allotment status will be available on August 13, 2026. The listing will be on the BSE and NSE platforms. The registrar of this IPO is Kfin Technologies Limited. Investors can check their allotment status after the subscription ends.

Molbio Diagnostics IPO Listing Date

Molbio Diagnostics IPO listing date is August 17, 2026. The listing will be on the BSE and NSE platforms. Retail investors can sell the shares after 10 AM on the listing day.

Molbio Diagnostics IPO: Listing Date, Lot Size, Price Band

Molbio Diagnostics Limited: About the Company

Molbio Diagnostics Limited is a molecular diagnostics company engaged in developing, manufacturing, and commercializing diagnostic solutions for infectious diseases and other healthcare applications. The company provides molecular testing platforms, diagnostic instruments, reagents, and test kits used by hospitals, laboratories, healthcare providers, and public health institutions.

The company focuses on delivering rapid and accurate diagnostic solutions with products designed for point-of-care testing. Its portfolio serves multiple disease segments, including tuberculosis, COVID-19, and other infectious diseases, while supporting healthcare systems across India and international markets.

Molbio Diagnostics IPO Objectives

Molbio Diagnostics Limited proposes to utilise the net proceeds from the fresh issue towards investment in research and development infrastructure, expansion of manufacturing facilities, and general corporate purposes.

Molbio Diagnostics Financials

(Amount in ₹ Crore)

Molbio Diagnostics IPO: Key Dates, Allotment, Listing Date

Molbio Diagnostics IPO Lot Size Details

Molbio Diagnostics IPO lot size is 18 shares. The minimum investment for the retail category is Rs 14,526, and for small HNI, the minimum investment is Rs 2,03,364.

Molbio Diagnostics IPO Promoter Holdings

The promoters of Molbio Diagnostics Limited are the existing promoter group. The promoter shareholding before the IPO was based on 11,27,59,750 shares; after the IPO, the total shareholding increased to 11,52,39,996 shares following the fresh issue.

Molbio Diagnostics IPO Registrar

Molbio Diagnostics IPO registrar is Kfin Technologies Limited. Investors can check their allotment status on the registrar's website using their PAN or Application Number.

How to Apply to the Molbio Diagnostics IPO

Investors can apply to the Molbio Diagnostics IPO through the Bigul trading app by clicking here. You can also check details of other upcoming IPOs listed on Bigul.

Molbio Diagnostics IPO FAQ

1. What are the details of the Molbio Diagnostics IPO?

Molbio Diagnostics IPO is a book-built issue of 1,16,46,246 equity shares aggregating up to Rs 940 crore. The issue comprises a fresh issue of Rs 200 crore and an offer for sale of Rs 740 crore.

2. When will the Molbio Diagnostics IPO open and close?

Molbio Diagnostics IPO open date is August 10, 2026, and the IPO close date is August 12, 2026. The initiation of the refund date is August 14, 2026, and the credit of shares will be on August 14, 2026.

3. What is Molbio Diagnostics IPO GMP?

Molbio Diagnostics IPO GMP quotation is Rs 0 as on August 5, 2026.

4. Write the details of IPO Allotment Status.

Molbio Diagnostics IPO allotment status will be available on August 13, 2026. The listing will be on the BSE and NSE platforms. The registrar of this IPO is Kfin Technologies Limited.

5. Who is the registrar and lead manager of Molbio Diagnostics IPO?

The registrar for the Molbio Diagnostics IPO is Kfin Technologies Limited. The book-running lead managers are Kotak Mahindra Capital Company Limited, IIFL Capital Services Limited, Jefferies India Private Limited, and Motilal Oswal Investment Advisors Limited.

-Tanisha Mulewa, Team Research Bigul

Bonanza Portfolio Limited is a member of NSE & BSE with SEBI Regn. No.: INZ000212137 | SEBI Regn. No. DP: IN-DP-62-2015 | PMS: INP 000000985 | Research Analyst ID: INH100001666)